NYT > Health: Imbruvica, Drug to Treat Blood Cancer, Gains F.D.A. Approval

Imbruvica, Drug to Treat Blood Cancer, Gains F.D.A. Approval

The drug has been approved by the Food and Drug Administration to treat relapses of a rare blood cancer called mantle cell lymphoma.

Source: http://www.nytimes.com/2013/11/14/business/drug-to-treat-blood-cancer-gains-fda-approval.html?partner=rss&emc=rss